Odyssey Health, Inc.

For the period ended Jan 31, 2026. Filed Mar 12, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jan 31, 2026 · Filed Mar 12, 2026

ODYYStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

	January 31,	July 31,
	2026	2025
Assets
Current assets:
Cash	$616,327	$19,084
Prepaid expenses and other current assets, net	104,977	30,639
Total current assets	721,304	49,723
Total assets	$721,304	$49,723
Liabilities and Stockholders’ Deficit
Current liabilities:
Accounts payable and accrued wages	$1,620,079	$1,615,357
Accounts payable and accrued wages, officers	1,857,004	1,858,443
Accrued interest	509,348	421,440
Asset purchase liability	1,125,026	1,125,026
Notes payable, officers and directors	100,000	100,000
Notes payable, net of unamortized debt discount and closing costs of $3,122,747 and $512, respectively	2,169,500	1,884,155
Derivative liabilities	3,936,166	–
Total current liabilities	11,317,123	7,004,421
Commitments and contingencies (Note 3)	–	–
Stockholders’ deficit:
Preferred stock, $0.001 par value, 100,000,000 shares authorized, no shares issued or outstanding	–	–
Common stock, $0.001 par value, 500,000,000 shares authorized, 99,853,763 and 96,709,763 shares issued and outstanding as of January 31, 2026 and July 31, 2025, respectively	99,854	96,710
Additional paid-in capital	56,135,234	55,694,429
Accumulated deficit	(66,830,907)	(62,745,837)
Total stockholders’ deficit	(10,595,819)	(6,954,698)
Total liabilities and stockholders’ deficit	$721,304	$49,723

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.